Home » VESTA THERAPEUTICS AWARDED RESEARCH GRANT
VESTA THERAPEUTICS AWARDED RESEARCH GRANT
Vesta Therapeutics announced the awarding of a Phase I Small Business Innovation Research Grant from the National Institutes of Diabetes and Digestive and Kidney Diseases (NIDDK), a division of the National Institutes of Health (NIH). This grant will support exploring the use of adipose derived adult stem (ADAS) cells as a therapeutic modality in liver disease.
ArriveNet (http://press.arrivenet.com/hea/article.php/655176.html)
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
07May
-
14May
-
30May